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Ethnopharmacological Relevance:  
Dillenia suffruticosa is traditionally used for treatment of cancerous growth including breast 
cancer in Malaysia. 
 
Aim of The Study:  
Dillenia suffruticosa is a well-known medicinal plant in Malaysia for the treatment of cancer. 
Nevertheless, no study has been reported the cytotoxicity of this plant towards MDA-MB-
231 triple-negative breast cancer cells. The present study was designed to investigate the 
mode of cell death and signalling pathways of MDA-MB-231 cells treated with 
dichloromethane Dillenia suffruticosa root extract (DCM-DS). 
 
Methods:  
Extraction of Dillenia suffruticosa root was performed by the use of sequential solvent 
procedure. The cytotoxicity of DCM-DS was determined by using MTT assay. The mode of 
cell death was evaluated by using an inverted light microscope and flow cytometry analysis 
using Annexin-V/PI. Cell cycle analysis and measurement of reactive oxygen species level 
were performed by using flow cytometry. The cells were treated with DCM-DS and 
antioxidants α-tocopherol or ascorbic acid to evaluate the involvement of ROS in the 
cytotoxicity of DCM-DS. Effect of DCM-DS on the expression of antioxidant, apoptotic, 
growth, survival genes and proteins were analysed by using GeXP-based multiplex system 
and Western blot, respectively. The cytotoxicity of compounds isolated from DCM-DS was 
evaluated towards MDA-MB-231 cells using MTT assay. 
 
Results:  
DCM-DS induced apoptosis, G2/M phase cell cycle arrest and oxidative stress in MDA-MB-
231 cells. The induction of apoptosis in MDA-MB-231 cells by DCM-DS is possibly due to 
the activation of pro-apoptotic JNK1 and down-regulation of anti-apoptotic ERK1, which in 
turn down-regulates anti-apoptotic BCL-2 to increase the BAX/BCL-2 ratio to initiate the 
mitochondrial apoptotic pathway. The cell cycle arrest in DCM-DS-treated MDA-MB-231 
cells is possibly via p53-independent but p21-dependent pathway. A total of 3 triterpene 
compounds were isolated from DCM-DS. Betulinic acid appears to be the most major and 
most cytotoxic compound in DCM-DS. 
 
Conclusion:  
The data suggest the potential application of DCM-DS in the treatment of triple-negative 
breast cancer. 
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